Eyal C. Attar, SVP, Chief Medical Officer, Director at Aprea Therapeutics, holds 93.92K shares in Vor Biopharma (Ticker: VOR), holds 57.56K shares in Aprea Therapeutics (Ticker: APRE).
What is the percentage of profitable transactions made by Eyal C. Attar?
The percentage of profitable transactions made by Eyal C. Attar is ―.
What is the average return per transaction made by Eyal C. Attar?
The average return per transaction made by Eyal C. Attar is ―.
What stocks does Eyal C. Attar hold?
Eyal C. Attar holds: APRE, VOR stocks.
What was Eyal C. Attar’s latest transaction?
Eyal C. Attar latest transaction was an Uninformative Sell of $869.13.
What was Eyal C. Attar's most profitable transaction?
Eyal C. Attar’s most profitable transaction was an Informative Buy of APRE stock on October 7, 2019. The return on the trade was 45.10%.
What is Eyal C. Attar's role in Aprea Therapeutics?
Eyal C. Attar's role in Aprea Therapeutics is SVP, Chief Medical Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.